Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
mineralocorticoid (RAT) | BDBM86690![]() (A 348441 | A-348441) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem Similars | Article PubMed | 440 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Abbott Laboratories Curated by PDSP Ki Database | J Pharmacol Exp Ther 314: 191-200 (2005) Article DOI: 10.1124/jpet.104.081257 BindingDB Entry DOI: 10.7270/Q2FT8J68 | ||||||||||||
More data for this Ligand-Target Pair | |||||||||||||
mineralocorticoid (RAT) | BDBM86689![]() (CAS_84371-65-3 | NSC_55245 | RU-486) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | Purchase PC cid PC sid PDB UniChem Patents Similars | Article PubMed | 640 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Abbott Laboratories Curated by PDSP Ki Database | J Pharmacol Exp Ther 314: 191-200 (2005) Article DOI: 10.1124/jpet.104.081257 BindingDB Entry DOI: 10.7270/Q2FT8J68 | ||||||||||||
More data for this Ligand-Target Pair | |||||||||||||
mineralocorticoid (RAT) | BDBM19199![]() ((R)-[(4aR,5S)-1-(4-fluorophenyl)-4a-methyl-1H,4H,4...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | CHEMBL PC cid PC sid UniChem Patents Similars | Article PubMed | n/a | n/a | >5.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Research Laboratories | Assay Description The IC50s were determined by incubating the receptors with radiolabeled aldosterone in the presence of full log scale concentrations (10-11 M to 10-6... | J Med Chem 47: 2441-52 (2004) Article DOI: 10.1021/jm030585i BindingDB Entry DOI: 10.7270/Q28W3BKZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
mineralocorticoid (RAT) | BDBM19200![]() ((S)-[(4aR,5S)-1-(4-fluorophenyl)-4a-methyl-1H,4H,4...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem Patents Similars | Article PubMed | n/a | n/a | >5.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Research Laboratories | Assay Description The IC50s were determined by incubating the receptors with radiolabeled aldosterone in the presence of full log scale concentrations (10-11 M to 10-6... | J Med Chem 47: 2441-52 (2004) Article DOI: 10.1021/jm030585i BindingDB Entry DOI: 10.7270/Q28W3BKZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
mineralocorticoid (RAT) | BDBM19201![]() ((1S)-1-[(4aR,5S)-1-(4-fluorophenyl)-4a-methyl-1H,4...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | >5.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Research Laboratories | Assay Description The IC50s were determined by incubating the receptors with radiolabeled aldosterone in the presence of full log scale concentrations (10-11 M to 10-6... | J Med Chem 47: 2441-52 (2004) Article DOI: 10.1021/jm030585i BindingDB Entry DOI: 10.7270/Q28W3BKZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
mineralocorticoid (RAT) | BDBM19207![]() ((1S)-1-[(4aR,5S)-1-(4-fluorophenyl)-4a-methyl-1H,4...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem Patents Similars | Article PubMed | n/a | n/a | >5.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Research Laboratories | Assay Description The IC50s were determined by incubating the receptors with radiolabeled aldosterone in the presence of full log scale concentrations (10-11 M to 10-6... | J Med Chem 47: 2441-52 (2004) Article DOI: 10.1021/jm030585i BindingDB Entry DOI: 10.7270/Q28W3BKZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Mineralocorticoid receptor (MR) (Homo sapiens (Human)) | BDBM238151![]() (US9394291, 1) | PDB GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | n/a | n/a | 1.40E+3 | n/a | n/a | n/a | n/a | n/a | n/a | |
AstraZeneca AB US Patent | Assay Description Test A1: Briefly, in Test A1 the assay was run in 384 well format in 10 mM Tris-HCl, pH 7.5, 0.5 mM EDTA 20 mM NaMoO4, 0.1 mM DTT and 10% glycerol at... | US Patent US9394291 (2016) BindingDB Entry DOI: 10.7270/Q2125RJS | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Mineralocorticoid receptor (MR) (Homo sapiens (Human)) | BDBM238152![]() (US9394291, 2 | US9394291, 2a) | PDB GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | n/a | n/a | 230 | n/a | n/a | n/a | n/a | n/a | n/a | |
AstraZeneca AB US Patent | Assay Description Test A1: Briefly, in Test A1 the assay was run in 384 well format in 10 mM Tris-HCl, pH 7.5, 0.5 mM EDTA 20 mM NaMoO4, 0.1 mM DTT and 10% glycerol at... | US Patent US9394291 (2016) BindingDB Entry DOI: 10.7270/Q2125RJS | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Mineralocorticoid receptor (MR) (Homo sapiens (Human)) | BDBM238155![]() (US9394291, 3 | US9394291, 3b) | PDB GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | n/a | n/a | 480 | n/a | n/a | n/a | n/a | n/a | n/a | |
AstraZeneca AB US Patent | Assay Description Test A1: Briefly, in Test A1 the assay was run in 384 well format in 10 mM Tris-HCl, pH 7.5, 0.5 mM EDTA 20 mM NaMoO4, 0.1 mM DTT and 10% glycerol at... | US Patent US9394291 (2016) BindingDB Entry DOI: 10.7270/Q2125RJS | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Mineralocorticoid receptor (MR) (Homo sapiens (Human)) | BDBM238155![]() (US9394291, 3 | US9394291, 3b) | PDB GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | n/a | n/a | 270 | n/a | n/a | n/a | n/a | n/a | n/a | |
AstraZeneca AB US Patent | Assay Description Test A1: Briefly, in Test A1 the assay was run in 384 well format in 10 mM Tris-HCl, pH 7.5, 0.5 mM EDTA 20 mM NaMoO4, 0.1 mM DTT and 10% glycerol at... | US Patent US9394291 (2016) BindingDB Entry DOI: 10.7270/Q2125RJS | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Mineralocorticoid receptor (MR) (Homo sapiens (Human)) | BDBM238158![]() (US9394291, 4) | PDB GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | n/a | n/a | 180 | n/a | n/a | n/a | n/a | n/a | n/a | |
AstraZeneca AB US Patent | Assay Description Test A1: Briefly, in Test A1 the assay was run in 384 well format in 10 mM Tris-HCl, pH 7.5, 0.5 mM EDTA 20 mM NaMoO4, 0.1 mM DTT and 10% glycerol at... | US Patent US9394291 (2016) BindingDB Entry DOI: 10.7270/Q2125RJS | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Mineralocorticoid receptor (MR) (Homo sapiens (Human)) | BDBM238159![]() (US9394291, 4a) | PDB GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | n/a | n/a | 130 | n/a | n/a | n/a | n/a | n/a | n/a | |
AstraZeneca AB US Patent | Assay Description Test A1: Briefly, in Test A1 the assay was run in 384 well format in 10 mM Tris-HCl, pH 7.5, 0.5 mM EDTA 20 mM NaMoO4, 0.1 mM DTT and 10% glycerol at... | US Patent US9394291 (2016) BindingDB Entry DOI: 10.7270/Q2125RJS | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Mineralocorticoid receptor (MR) (Homo sapiens (Human)) | BDBM238161![]() (US9394291, 5a) | PDB GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | n/a | n/a | 16 | n/a | n/a | n/a | n/a | n/a | n/a | |
AstraZeneca AB US Patent | Assay Description Test A1: Briefly, in Test A1 the assay was run in 384 well format in 10 mM Tris-HCl, pH 7.5, 0.5 mM EDTA 20 mM NaMoO4, 0.1 mM DTT and 10% glycerol at... | US Patent US9394291 (2016) BindingDB Entry DOI: 10.7270/Q2125RJS | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Mineralocorticoid receptor (MR) (Homo sapiens (Human)) | BDBM238162![]() (US9394291, 5b) | PDB GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | n/a | n/a | 4.90E+3 | n/a | n/a | n/a | n/a | n/a | n/a | |
AstraZeneca AB US Patent | Assay Description Test A1: Briefly, in Test A1 the assay was run in 384 well format in 10 mM Tris-HCl, pH 7.5, 0.5 mM EDTA 20 mM NaMoO4, 0.1 mM DTT and 10% glycerol at... | US Patent US9394291 (2016) BindingDB Entry DOI: 10.7270/Q2125RJS | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Mineralocorticoid receptor (MR) (Homo sapiens (Human)) | BDBM238163![]() (US9394291, 6 | US9394291, 6a | US9394291, 6b) | PDB GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | n/a | n/a | 82 | n/a | n/a | n/a | n/a | n/a | n/a | |
AstraZeneca AB US Patent | Assay Description Test A1: Briefly, in Test A1 the assay was run in 384 well format in 10 mM Tris-HCl, pH 7.5, 0.5 mM EDTA 20 mM NaMoO4, 0.1 mM DTT and 10% glycerol at... | US Patent US9394291 (2016) BindingDB Entry DOI: 10.7270/Q2125RJS | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Mineralocorticoid receptor (MR) (Homo sapiens (Human)) | BDBM238163![]() (US9394291, 6 | US9394291, 6a | US9394291, 6b) | PDB GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | n/a | n/a | 13 | n/a | n/a | n/a | n/a | n/a | n/a | |
AstraZeneca AB US Patent | Assay Description Test A1: Briefly, in Test A1 the assay was run in 384 well format in 10 mM Tris-HCl, pH 7.5, 0.5 mM EDTA 20 mM NaMoO4, 0.1 mM DTT and 10% glycerol at... | US Patent US9394291 (2016) BindingDB Entry DOI: 10.7270/Q2125RJS | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Mineralocorticoid receptor (MR) (Homo sapiens (Human)) | BDBM238163![]() (US9394291, 6 | US9394291, 6a | US9394291, 6b) | PDB GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | n/a | n/a | 1.90E+3 | n/a | n/a | n/a | n/a | n/a | n/a | |
AstraZeneca AB US Patent | Assay Description Test A1: Briefly, in Test A1 the assay was run in 384 well format in 10 mM Tris-HCl, pH 7.5, 0.5 mM EDTA 20 mM NaMoO4, 0.1 mM DTT and 10% glycerol at... | US Patent US9394291 (2016) BindingDB Entry DOI: 10.7270/Q2125RJS | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Mineralocorticoid receptor (MR) (Homo sapiens (Human)) | BDBM238166![]() (US9394291, 7) | PDB GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | n/a | n/a | 9.5 | n/a | n/a | n/a | n/a | n/a | n/a | |
AstraZeneca AB US Patent | Assay Description Test A1: Briefly, in Test A1 the assay was run in 384 well format in 10 mM Tris-HCl, pH 7.5, 0.5 mM EDTA 20 mM NaMoO4, 0.1 mM DTT and 10% glycerol at... | US Patent US9394291 (2016) BindingDB Entry DOI: 10.7270/Q2125RJS | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Mineralocorticoid receptor (MR) (Homo sapiens (Human)) | BDBM238167![]() (US9394291, 8 | US9394291, 8a | US9394291, 8b) | PDB GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | n/a | n/a | 40 | n/a | n/a | n/a | n/a | n/a | n/a | |
AstraZeneca AB US Patent | Assay Description Test A1: Briefly, in Test A1 the assay was run in 384 well format in 10 mM Tris-HCl, pH 7.5, 0.5 mM EDTA 20 mM NaMoO4, 0.1 mM DTT and 10% glycerol at... | US Patent US9394291 (2016) BindingDB Entry DOI: 10.7270/Q2125RJS | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Mineralocorticoid receptor (MR) (Homo sapiens (Human)) | BDBM238167![]() (US9394291, 8 | US9394291, 8a | US9394291, 8b) | PDB GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | n/a | n/a | 1.60E+3 | n/a | n/a | n/a | n/a | n/a | n/a | |
AstraZeneca AB US Patent | Assay Description Test A1: Briefly, in Test A1 the assay was run in 384 well format in 10 mM Tris-HCl, pH 7.5, 0.5 mM EDTA 20 mM NaMoO4, 0.1 mM DTT and 10% glycerol at... | US Patent US9394291 (2016) BindingDB Entry DOI: 10.7270/Q2125RJS | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Mineralocorticoid receptor (MR) (Homo sapiens (Human)) | BDBM238167![]() (US9394291, 8 | US9394291, 8a | US9394291, 8b) | PDB GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | n/a | n/a | 10 | n/a | n/a | n/a | n/a | n/a | n/a | |
AstraZeneca AB US Patent | Assay Description Test A1: Briefly, in Test A1 the assay was run in 384 well format in 10 mM Tris-HCl, pH 7.5, 0.5 mM EDTA 20 mM NaMoO4, 0.1 mM DTT and 10% glycerol at... | US Patent US9394291 (2016) BindingDB Entry DOI: 10.7270/Q2125RJS | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Mineralocorticoid receptor (MR) (Homo sapiens (Human)) | BDBM238151![]() (US9394291, 1) | PDB GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | n/a | n/a | 2.90E+3 | n/a | n/a | n/a | n/a | n/a | n/a | |
AstraZeneca AB US Patent | Assay Description Test A2: Briefly, in Test A1 the assay was run in 384 well format in 10 mM Tris-HCl, pH 7.5, 0.5 mM EDTA 20 mM NaMoO4, 0.1 mM DTT and 10% glycerol at... | US Patent US9394291 (2016) BindingDB Entry DOI: 10.7270/Q2125RJS | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Mineralocorticoid receptor (MR) (Homo sapiens (Human)) | BDBM238152![]() (US9394291, 2 | US9394291, 2a) | PDB GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | n/a | n/a | 1.80E+3 | n/a | n/a | n/a | n/a | n/a | n/a | |
AstraZeneca AB US Patent | Assay Description Test A2: Briefly, in Test A1 the assay was run in 384 well format in 10 mM Tris-HCl, pH 7.5, 0.5 mM EDTA 20 mM NaMoO4, 0.1 mM DTT and 10% glycerol at... | US Patent US9394291 (2016) BindingDB Entry DOI: 10.7270/Q2125RJS | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Mineralocorticoid receptor (MR) (Homo sapiens (Human)) | BDBM238158![]() (US9394291, 4) | PDB GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | n/a | n/a | 740 | n/a | n/a | n/a | n/a | n/a | n/a | |
AstraZeneca AB US Patent | Assay Description Test A2: Briefly, in Test A1 the assay was run in 384 well format in 10 mM Tris-HCl, pH 7.5, 0.5 mM EDTA 20 mM NaMoO4, 0.1 mM DTT and 10% glycerol at... | US Patent US9394291 (2016) BindingDB Entry DOI: 10.7270/Q2125RJS | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Mineralocorticoid receptor (MR) (Homo sapiens (Human)) | BDBM238159![]() (US9394291, 4a) | PDB GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | n/a | n/a | 240 | n/a | n/a | n/a | n/a | n/a | n/a | |
AstraZeneca AB US Patent | Assay Description Test A2: Briefly, in Test A1 the assay was run in 384 well format in 10 mM Tris-HCl, pH 7.5, 0.5 mM EDTA 20 mM NaMoO4, 0.1 mM DTT and 10% glycerol at... | US Patent US9394291 (2016) BindingDB Entry DOI: 10.7270/Q2125RJS | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Mineralocorticoid receptor (MR) (Homo sapiens (Human)) | BDBM238163![]() (US9394291, 6 | US9394291, 6a | US9394291, 6b) | PDB GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | n/a | n/a | 58 | n/a | n/a | n/a | n/a | n/a | n/a | |
AstraZeneca AB US Patent | Assay Description Test A2: Briefly, in Test A1 the assay was run in 384 well format in 10 mM Tris-HCl, pH 7.5, 0.5 mM EDTA 20 mM NaMoO4, 0.1 mM DTT and 10% glycerol at... | US Patent US9394291 (2016) BindingDB Entry DOI: 10.7270/Q2125RJS | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
mineralocorticoid (RAT) | BDBM50004519![]() (CHEMBL2181929) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | CHEMBL PC cid PC sid UniChem | Article PubMed | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc. Curated by ChEMBL | Assay Description Binding affinity to rat mineralocorticoid receptor | J Med Chem 55: 7957-66 (2012) Article DOI: 10.1021/jm300806c BindingDB Entry DOI: 10.7270/Q2QC04N3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
mineralocorticoid (RAT) | BDBM50167790![]() (1-(4-fluorophenyl)-4',4a,6'-trimethyl-(4'S,4aS,6'S...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | CHEMBL PC cid PC sid UniChem Patents Similars | Article PubMed | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Research Laboratories Curated by ChEMBL | Assay Description Binding affinity for rat mineralocorticoid receptor | Bioorg Med Chem Lett 15: 2926-31 (2005) Article DOI: 10.1016/j.bmcl.2005.03.027 BindingDB Entry DOI: 10.7270/Q2X34X0Q | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
mineralocorticoid (RAT) | BDBM50167799![]() (1-(4-fluorophenyl)-4a-methyl-4',5'-divinyl-(4'R,4a...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | CHEMBL PC cid PC sid UniChem Patents Similars | Article PubMed | n/a | n/a | 7.40E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Research Laboratories Curated by ChEMBL | Assay Description Binding affinity for rat mineralocorticoid receptor | Bioorg Med Chem Lett 15: 2926-31 (2005) Article DOI: 10.1016/j.bmcl.2005.03.027 BindingDB Entry DOI: 10.7270/Q2X34X0Q | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
mineralocorticoid (RAT) | BDBM50167808![]() (1-(4-fluorophenyl)-4a-methyl-(4aS)-spiro[4,4a,5,6,...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | CHEMBL PC cid PC sid UniChem Patents Similars | Article PubMed | n/a | n/a | 7.56E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Research Laboratories Curated by ChEMBL | Assay Description Binding affinity for rat mineralocorticoid receptor | Bioorg Med Chem Lett 15: 2926-31 (2005) Article DOI: 10.1016/j.bmcl.2005.03.027 BindingDB Entry DOI: 10.7270/Q2X34X0Q | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
mineralocorticoid (RAT) | BDBM50167795![]() (1-(4-fluorophenyl)-4',4a,5'-trimethyl-(4'R,4aS,5'R...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | CHEMBL PC cid PC sid UniChem Patents Similars | Article PubMed | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Research Laboratories Curated by ChEMBL | Assay Description Binding affinity for rat mineralocorticoid receptor | Bioorg Med Chem Lett 15: 2926-31 (2005) Article DOI: 10.1016/j.bmcl.2005.03.027 BindingDB Entry DOI: 10.7270/Q2X34X0Q | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
mineralocorticoid (RAT) | BDBM50167794![]() (1-(4-fluorophenyl)-4a-methyl-(4aS)-spiro[1,4,4a,5,...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | CHEMBL PC cid PC sid UniChem Patents Similars | Article PubMed | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Research Laboratories Curated by ChEMBL | Assay Description Binding affinity for rat mineralocorticoid receptor | Bioorg Med Chem Lett 15: 2926-31 (2005) Article DOI: 10.1016/j.bmcl.2005.03.027 BindingDB Entry DOI: 10.7270/Q2X34X0Q | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
mineralocorticoid (RAT) | BDBM50167796![]() (1-(4-fluorophenyl)-4a-methyl-4',5'-divinyl-(4'R,4a...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | CHEMBL PC cid PC sid UniChem Patents Similars | Article PubMed | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Research Laboratories Curated by ChEMBL | Assay Description Binding affinity for rat mineralocorticoid receptor | Bioorg Med Chem Lett 15: 2926-31 (2005) Article DOI: 10.1016/j.bmcl.2005.03.027 BindingDB Entry DOI: 10.7270/Q2X34X0Q | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
mineralocorticoid (RAT) | BDBM18161![]() ((1S,2S,7S,10R,11S,14S,15S)-14-hydroxy-2,15-dimethy...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | Purchase CHEMBL KEGG MMDB PC cid PC sid PDB UniChem Patents Similars | Article PubMed | n/a | n/a | 2.10E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Kaken Pharmaceutical Co., Ltd Curated by ChEMBL | Assay Description Displacement of [3H]aldosterone from Sprague-Dawley rat MR by liquid scintillation counting | Bioorg Med Chem Lett 21: 1744-7 (2011) Article DOI: 10.1016/j.bmcl.2011.01.073 BindingDB Entry DOI: 10.7270/Q2474B55 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
mineralocorticoid (RAT) | BDBM18525![]() (Bicalutamide | CHEMBL409 | N-[4-cyano-3-(trifluoro...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | Purchase CHEMBL DrugBank KEGG PC cid PC sid PDB UniChem Patents Similars | Article PubMed | n/a | n/a | >1.00E+6 | n/a | n/a | n/a | n/a | n/a | n/a |
Kaken Pharmaceutical Co., Ltd Curated by ChEMBL | Assay Description Displacement of [3H]aldosterone from Sprague-Dawley rat MR by liquid scintillation counting | Bioorg Med Chem Lett 21: 1744-7 (2011) Article DOI: 10.1016/j.bmcl.2011.01.073 BindingDB Entry DOI: 10.7270/Q2474B55 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
mineralocorticoid (RAT) | BDBM50338693![]() (2-methyl-2-((3aR,4S,9bS)-8-nitro-3a,4,5,9b-tetrahy...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | Purchase CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | 6.30E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Kaken Pharmaceutical Co., Ltd Curated by ChEMBL | Assay Description Displacement of [3H]aldosterone from Sprague-Dawley rat MR by liquid scintillation counting | Bioorg Med Chem Lett 21: 1744-7 (2011) Article DOI: 10.1016/j.bmcl.2011.01.073 BindingDB Entry DOI: 10.7270/Q2474B55 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
mineralocorticoid (RAT) | BDBM19214![]() ((1S,2R,10S,11S,14S,15R,17S)-17-hydroxy-14-(2-hydro...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | Purchase DrugBank KEGG PC cid PC sid PDB UniChem Similars | Article PubMed | n/a | n/a | 43 | n/a | n/a | n/a | n/a | n/a | n/a |
Kaken Pharmaceutical Co., Ltd Curated by ChEMBL | Assay Description Displacement of [3H]aldosterone from Sprague-Dawley rat MR by liquid scintillation counting | Bioorg Med Chem Lett 21: 1744-7 (2011) Article DOI: 10.1016/j.bmcl.2011.01.073 BindingDB Entry DOI: 10.7270/Q2474B55 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
mineralocorticoid (RAT) | BDBM50336275![]() (1-oxo-1,3,4,5,6,7,8,9-octahydrobenzo[c][1]oxacyclo...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | 580 | n/a | n/a | n/a | n/a | n/a | n/a |
Chinese Academy of Sciences Curated by ChEMBL | Assay Description Antagonist activity at rat mineralocorticoid receptor-ligand binding domain expressed in AH109 yeast cells co expressing pGADT7-hSRC-1 by two hybrid ... | Bioorg Med Chem Lett 21: 1171-5 (2011) Article DOI: 10.1016/j.bmcl.2010.12.101 BindingDB Entry DOI: 10.7270/Q2X92BKM | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
mineralocorticoid (RAT) | BDBM50336276![]() (1-oxo-1,3,4,5,6,7,8,9,10,11-decahydrobenzo[c][1]ox...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | 820 | n/a | n/a | n/a | n/a | n/a | n/a |
Chinese Academy of Sciences Curated by ChEMBL | Assay Description Antagonist activity at rat mineralocorticoid receptor-ligand binding domain expressed in AH109 yeast cells co expressing pGADT7-hSRC-1 by two hybrid ... | Bioorg Med Chem Lett 21: 1171-5 (2011) Article DOI: 10.1016/j.bmcl.2010.12.101 BindingDB Entry DOI: 10.7270/Q2X92BKM | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
mineralocorticoid (RAT) | BDBM50336277![]() (1-oxo-3,4,5,6,7,8,9,10-octahydro-1H-benzo[c][1]oxa...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | 1.11E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Chinese Academy of Sciences Curated by ChEMBL | Assay Description Antagonist activity at rat mineralocorticoid receptor-ligand binding domain expressed in AH109 yeast cells co expressing pGADT7-hSRC-1 by two hybrid ... | Bioorg Med Chem Lett 21: 1171-5 (2011) Article DOI: 10.1016/j.bmcl.2010.12.101 BindingDB Entry DOI: 10.7270/Q2X92BKM | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
mineralocorticoid (RAT) | BDBM50336278![]() ((R)-3-methyl-1-oxo-3,4,5,6,7,8,9,10-octahydro-1H-b...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | 2.78E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Chinese Academy of Sciences Curated by ChEMBL | Assay Description Antagonist activity at rat mineralocorticoid receptor-ligand binding domain expressed in AH109 yeast cells co expressing pGADT7-hSRC-1 by two hybrid ... | Bioorg Med Chem Lett 21: 1171-5 (2011) Article DOI: 10.1016/j.bmcl.2010.12.101 BindingDB Entry DOI: 10.7270/Q2X92BKM | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
mineralocorticoid (RAT) | BDBM50336274![]() (1-oxo-3,4,5,6,7,8,9,10,11,12-decahydro-1H-benzo[c]...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | 2.90E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Chinese Academy of Sciences Curated by ChEMBL | Assay Description Antagonist activity at rat mineralocorticoid receptor-ligand binding domain expressed in AH109 yeast cells co expressing pGADT7-hSRC-1 by two hybrid ... | Bioorg Med Chem Lett 21: 1171-5 (2011) Article DOI: 10.1016/j.bmcl.2010.12.101 BindingDB Entry DOI: 10.7270/Q2X92BKM | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
mineralocorticoid (RAT) | BDBM50336279![]() ((R)-3-methyl-1-oxo-3,4,5,6,7,8,9,10-octahydro-1H-b...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | CHEMBL PC cid PC sid UniChem | Article PubMed | n/a | n/a | 6.51E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Chinese Academy of Sciences Curated by ChEMBL | Assay Description Antagonist activity at rat mineralocorticoid receptor-ligand binding domain expressed in AH109 yeast cells co expressing pGADT7-hSRC-1 by two hybrid ... | Bioorg Med Chem Lett 21: 1171-5 (2011) Article DOI: 10.1016/j.bmcl.2010.12.101 BindingDB Entry DOI: 10.7270/Q2X92BKM | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
mineralocorticoid (RAT) | BDBM50336280![]() ((R)-de-O-methyllasioplodin | CHEMBL1669749) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | Purchase CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | 8.93E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Chinese Academy of Sciences Curated by ChEMBL | Assay Description Antagonist activity at rat mineralocorticoid receptor-ligand binding domain expressed in AH109 yeast cells co expressing pGADT7-hSRC-1 by two hybrid ... | Bioorg Med Chem Lett 21: 1171-5 (2011) Article DOI: 10.1016/j.bmcl.2010.12.101 BindingDB Entry DOI: 10.7270/Q2X92BKM | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
mineralocorticoid (RAT) | BDBM50336281![]() ((R,Z)-12,14-dimethoxy-3-methyl-3,4,5,6,9,10-hexahy...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | CHEMBL PC cid PC sid UniChem | Article PubMed | n/a | n/a | 1.66E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Chinese Academy of Sciences Curated by ChEMBL | Assay Description Antagonist activity at rat mineralocorticoid receptor-ligand binding domain expressed in AH109 yeast cells co expressing pGADT7-hSRC-1 by two hybrid ... | Bioorg Med Chem Lett 21: 1171-5 (2011) Article DOI: 10.1016/j.bmcl.2010.12.101 BindingDB Entry DOI: 10.7270/Q2X92BKM | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
mineralocorticoid (RAT) | BDBM50336282![]() ((R)-3-methyl-1-oxo-3,4,5,6,7,8,9,10-octahydro-1H-b...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | 3.17E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Chinese Academy of Sciences Curated by ChEMBL | Assay Description Antagonist activity at rat mineralocorticoid receptor-ligand binding domain expressed in AH109 yeast cells co expressing pGADT7-hSRC-1 by two hybrid ... | Bioorg Med Chem Lett 21: 1171-5 (2011) Article DOI: 10.1016/j.bmcl.2010.12.101 BindingDB Entry DOI: 10.7270/Q2X92BKM | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
mineralocorticoid (RAT) | BDBM18161![]() ((1S,2S,7S,10R,11S,14S,15S)-14-hydroxy-2,15-dimethy...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | Purchase CHEMBL KEGG MMDB PC cid PC sid PDB UniChem Patents Similars | Article PubMed | n/a | n/a | 2.10E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Kaken Pharmaceutical Co., Ltd Curated by ChEMBL | Assay Description Displacement of [3H]Aldo from mineralocorticoid receptor in Sprague-Dawley rat kidney after 2 hrs by liquid scintillation counting | Bioorg Med Chem Lett 21: 6310-3 (2011) Checked by Author Article DOI: 10.1016/j.bmcl.2011.08.118 BindingDB Entry DOI: 10.7270/Q2JH3MKZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
mineralocorticoid (RAT) | BDBM50355936![]() (CHEMBL1910411) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | 1.40E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Kaken Pharmaceutical Co., Ltd Curated by ChEMBL | Assay Description Displacement of [3H]Aldo from mineralocorticoid receptor in Sprague-Dawley rat kidney after 2 hrs by liquid scintillation counting | Bioorg Med Chem Lett 21: 6310-3 (2011) Checked by Author Article DOI: 10.1016/j.bmcl.2011.08.118 BindingDB Entry DOI: 10.7270/Q2JH3MKZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
mineralocorticoid (RAT) | BDBM18525![]() (Bicalutamide | CHEMBL409 | N-[4-cyano-3-(trifluoro...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | Purchase CHEMBL DrugBank KEGG PC cid PC sid PDB UniChem Patents Similars | Article PubMed | n/a | n/a | 3.60E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Kaken Pharmaceutical Co., Ltd Curated by ChEMBL | Assay Description Displacement of [3H]Aldo from mineralocorticoid receptor in Sprague-Dawley rat kidney after 2 hrs by liquid scintillation counting | Bioorg Med Chem Lett 21: 6310-3 (2011) Checked by Author Article DOI: 10.1016/j.bmcl.2011.08.118 BindingDB Entry DOI: 10.7270/Q2JH3MKZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
mineralocorticoid (RAT) | BDBM19214![]() ((1S,2R,10S,11S,14S,15R,17S)-17-hydroxy-14-(2-hydro...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | Purchase DrugBank KEGG PC cid PC sid PDB UniChem Similars | Article PubMed | n/a | n/a | 43 | n/a | n/a | n/a | n/a | n/a | n/a |
Kaken Pharmaceutical Co., Ltd Curated by ChEMBL | Assay Description Displacement of [3H]Aldo from mineralocorticoid receptor in Sprague-Dawley rat kidney after 2 hrs by liquid scintillation counting | Bioorg Med Chem Lett 21: 6310-3 (2011) Checked by Author Article DOI: 10.1016/j.bmcl.2011.08.118 BindingDB Entry DOI: 10.7270/Q2JH3MKZ | |||||||||||
More data for this Ligand-Target Pair |
Displayed 1 to 50 (of 54 total ) | Next | Last >> |